CareTechGuide.co.uk – eMAR for Residential Care Homes
Dated 17th March, 2026, produced by Liam Palmer, Care Tech Guide.
The Complete Independent Buyer’s Guide — Nursing Homes and Residential Care Homes
All 7 standalone main eMAR systems profiled and rated • Nursing homes and residential care homes
| WHAT’S IN THIS REPORT
Section 1: Buying Guide – advice Section 2: Key considerations for considering which E Mar system Section 3: At a glance – Standalone E Mar for care homes Section 4: Background and supporting information Independent research. No supplier has paid for inclusion.
|
Disclaimer – The information contained therein is based on research for various sources, independently checked and edited by those with sector knowledge but limited by the quality of original data sources and supplier corroboration available. If readers have suggestions for edits, do e mail [email protected] stating the source of your proposed change, so it can considered.
Choosing an eMAR system is a major decision for a care home operator. There are two approaches — both valid, but not equal in risk or effort.
What a Good Procurement Process Must Cover
Beyond features, focus on:
Option 1 — Procure It Yourself
Many providers do this successfully, but there are consistent blind spots:
You can still make a good decision — but risks increase without deeper insight.
Option 2 — Independent Expert Support
An independent advisor helps close the gaps:
Recommendation — Independent Advisory
Need help? CareTechGuide provides independent, unbiased support to help care providers select and implement the right technology. Support ranges from advice through to full procurement, implementation and training. We promise that you will only be given independent advice and provide context for all options outlined.
Contact [email protected]
For those who would like to look deeper into the systems and suppliers available, core distinctions – here is the body of the guide together with background information relating to Emar relating to compliance and meds administration.
| Basic Digital MAR Chart
A digital version of the paper chart. Staff enter medication data manually. Reduces paper but does not eliminate transcription errors and provides no pharmacy integration. Carries most of the same risks as paper MAR. |
| Full eMAR with Pharmacy Integration
Medication data flows automatically from the dispensing pharmacy into the system. Prescriptions update in real time. Manual transcription is eliminated. This is the standard all serious residential care providers should be targeting. |
The suppliers in this section provide dedicated, specialist eMAR solutions designed exclusively for care homes — nursing homes and residential homes. These are standalone or hardware-plus-software systems where medication management is the primary product purpose. They integrate with care planning software but are not an all-in-one platform.
| Who this section is for
Care homes that want the deepest possible medication management capability from a specialist system. Nursing homes with complex clinical requirements. Multi-site groups wanting best-of-breed eMAR that integrates with whichever care planning system they use. |
Pharmacy Integration = automated feed from dispensing pharmacy into eMAR, removing manual transcription. Barcode Scan = verification at point of administration.
| Supplier | Type | Best For | Pharmacy Integration | Care Planning | Barcode | Contract | Tier |
| ATLAS eMAR (PCS) | Standalone | PCS care home users | Yes — pharmacy portal | PCS native | ✅ | Flexible | T1 |
| Omnicell | H/W + S/W | Nursing homes + resi | Deep — MDS automated | Nourish + major | ✅ | H/W tie-in | T1 |
| Electronic MAR (Graphix Asset) | SaaS | All residential types | Yes — pharmacy link | Multiple | ✅ | Flexible | T1 |
| Camascope (VCare) | Standalone | Multi-site homes | Strong — DM+D | Nourish, PCS, others | ✅ | Flexible | T1 |
| MED e-care | Standalone | Multi-site groups | Strong — DM+D | Most platforms | ✅ | Flexible | T1 |
| HxCare (Positive Solutions) | Standalone | Smaller homes | Deep — Analyst PMR | Building | Limited | Pharmacy-funded | T2 |
| CareMeds | Standalone | CareMeds clients | Native (CareMeds) | Limited | ✅ | Flexible | T2 |
Need help? CareTechGuide provides independent, unbiased support to help care providers select and implement the right technology. Support ranges from advice through to full procurement, implementation and training — Contact:[email protected].
TIER 1 — Established, Purpose-Built, Widely Deployed |
Proven track records in UK residential care, deep medication features, strong pharmacy integration. The benchmark for care homes evaluating this market.
1. ATLAS eMAR — Person Centred Software [TIER 1]Standalone eMAR | Residential and nursing care homes |
| ATLAS eMAR is part of Person Centred Software’s Connected Care Platform. Its defining feature is barcode scanning at point of administration — every medication arrives with a unique barcode linked to the resident’s profile, and the system issues a real-time alert if there is any mismatch between medication, dose and resident. For care homes already using PCS digital care planning — the most widely deployed in the UK — ATLAS is the natural and most cost-effective first choice. |
| Strengths
• Barcode verification at point of care — strongest error prevention on the market • Native integration with PCS care planning — no data duplication or manual reconciliation • Part of the Connected Care Platform including family engagement and wellbeing tools • Strong CQC audit trail — inspection-ready reporting built in from day one • Backed by the largest digital care planning provider in the UK social care market Best For Care homes of any size currently using or considering Person Centred Software. Nursing homes with complex medication rounds and high administration volumes. |
2. Omnicell [TIER 1]Hardware + Software | Nursing homes, large groups, and residential homes |
| Omnicell is widely described as the UK’s leading care home medication administration solution. Their hardware-plus-software model supplies automated dispensing units, tablets, installation, training and technical support as a single package — unmatched for high-volume nursing homes. Importantly, Omnicell also offers a software-only product designed for residential care homes where full hardware is not required. This makes Omnicell relevant across the full spectrum of care home types, from a 20-bed residential home to a 150-bed nursing home group. |
| Strengths
• Market leader — widely recognised by CQC inspectors and pharmacy partners • Deep pharmacy integration including automated MDS dispensing for nursing homes • Software-only option for residential care homes — no hardware required • Full turnkey hardware service for nursing homes — installation, training and support in one relationship • Well-established integration with Nourish Care Best For Large nursing homes and care home groups for the full hardware suite. Residential care homes via the software product. Groups wanting a single trusted eMAR partner across all their settings. |
3. Electronic MAR — Graphix Asset [TIER 1]SaaS eMAR | All residential care home types — nursing and residential |
| Electronic MAR by Graphix Asset is a dedicated SaaS eMAR solution for care homes. Designed for the full medication administration workflow in residential settings — from pharmacy-linked prescriptions through to point-of-care administration recording. Offers a clean, straightforward approach particularly well suited to care homes wanting a dedicated eMAR without the hardware commitment of platforms like Omnicell. Supports integration with care planning systems and provides CQC-ready audit trails. |
| Strengths
• Dedicated eMAR — medication management is the core purpose, not a module • SaaS delivery — no hardware required, accessible pricing, lower switching costs • Pharmacy integration for automated prescription updates • CQC audit trail and reporting built in • Suitable for both nursing homes and residential homes • Designed for straightforward adoption without complex implementation Best For Residential and nursing homes wanting a dedicated, accessible SaaS eMAR without hardware commitments. Good option for homes evaluating standalone eMAR for the first time. |
4. Camascope (formerly VCare Systems) [TIER 1]Standalone eMAR | Residential and nursing homes, multi-site groups |
| Camascope is the rebranded name of VCare Systems — same company, same product, new brand. Both names still appear in the market. Camascope has built a strong reputation for real-time alerts, in-app clinical safeguards and a 24/7 human support model that genuinely differentiates it from larger, more corporate competitors. Missed dose alerts, PRN insights and audit reporting are all built in. User feedback consistently highlights ease of adoption and responsive support. Used by 2,000+ health and social care providers. |
| Strengths
• Dedicated eMAR specialist — medication depth is a core product priority • 24/7 human support — not a chatbot; a meaningful differentiator in the market • Strong integrations with Nourish Care and Person Centred Software • Real-time missed dose alerts and PRN tracking built in as standard • NHS DM+D medication database integration reduces manual entry errors • No hardware dependency — software-only, lower switching costs • Offline mode — medicines can be recorded even without internet connection Best For Care homes and nursing homes of any size wanting best-in-class standalone eMAR with strong integrations and genuinely responsive support. |
5. MED e-care [TIER 1]Standalone eMAR | Multi-site care home groups |
| MED e-care is a well-established standalone eMAR with a strong open integration philosophy — their position is that all care technology must openly share data streams. They use NHS DM+D codes, integrate with most major care planning systems, and are the preferred choice for providers wanting genuine best-of-breed medication management without being locked into a single software ecosystem. Strategic partnership with PainChek announced in 2025 extends their clinical capability. |
| Strengths
• Open integration philosophy — connects to most major care planning platforms • NHS DM+D code standards — pharmacy-grade data quality throughout • No single-vendor dependency — full flexibility in the technology stack • Experienced UK social care specialist with established pharmacy relationships • Strategic PainChek partnership (2025) — integrated AI pain assessment capability Best For Multi-site care home groups wanting specialist standalone eMAR that works alongside existing care planning software regardless of vendor. |
TIER 2 — Credible within Specific Contexts |
Strong use cases for specific providers — pharmacy-ecosystem dependent, smaller settings, or niche geographic focus.
6. HxCare — Positive Solutions [TIER 2]Standalone eMAR | Smaller residential care homes, pharmacy-funded model |
| HxCare is a newer entrant from Positive Solutions, backed by 30 years of pharmacy technology expertise. Developed in close collaboration with care homes to prioritise usability for all technical literacy levels. The standout commercial feature is its pharmacy-funded rollout model — community pharmacies enrolling in the HxCare Affiliate Programme can subsidise or fully fund the system for their care home clients, removing the upfront cost barrier for smaller homes. |
| Strengths
• Pharmacy-funded model available — removes cost barrier for smaller homes enrolled with a participating pharmacy • 30 years of pharmacy technology background embedded in the product design • Built with care home staff — genuine focus on usability for non-technical teams • Deep integration with Analyst PMR pharmacy management system • No hardware dependency — software-only, flexible commercial model Best For Smaller residential care homes and those whose community pharmacy uses the Analyst PMR system. Providers seeking a pharmacy-funded route to eMAR. |
7. CareMeds [TIER 2]Standalone eMAR | Care homes using CareMeds dispensing pharmacy |
| CareMeds eMAR uses photographic identification of resident and medication, supported by 2D barcodes, linking the care home directly to the pharmacy and eMAR systems. Tightly integrated with the MultiMeds blister pack dispensing system. Available across UK, Ireland, France, Malta and Gibraltar. CareMeds eMAR is only available to CareMeds pharmacy customers — it is the technology layer of their pharmacy service, not an independent purchase. |
| Strengths
• Photographic and 2D barcode verification — strong error prevention at point of administration • Tightly integrated with MultiMeds blister pack dispensing • Available internationally across UK, Ireland and Europe • Positive feedback from care home technology leads who have independently evaluated the market Best For Care homes already using or actively considering CareMeds as their dispensing pharmacy. |
Need help? CareTechGuide provides independent, unbiased support to help care providers select and implement the right technology. Support ranges from advice through to full procurement, implementation and training — tailored to your budget and strategy,and delivered via vetted independent experts. Contact: [email protected].
Medication management in UK care homes is closely regulated because mistakes can seriously harm residents. The process of dispensing, administering, recording and storing medicines is directly linked to the standards set by the Care Quality Commission (CQC), and getting it wrong carries significant consequences — for residents, for care staff, and for the organisation as a whole.
Regulatory and compliance requirements
The CQC requires care providers to manage medicines safely under its Fundamental Standards. This means medicines must be prescribed correctly, dispensed safely, administered at the correct time and dosage, recorded accurately, and stored and disposed of safely. If medication is handled incorrectly or records are poorly maintained, the service may be judged to have breached these standards — which can lead to enforcement action by the CQC and potentially involve other regulators and safeguarding authorities.
Clear and accurate documentation is essential. Care homes must maintain proper records such as Medication Administration Records (MAR charts) and inventory logs. Poor record keeping can lead to missed doses, incorrect medicines being given, incorrect dosages, and an inability to track stock or identify discrepancies. These errors are not only clinical risks but may also represent regulatory breaches. Serious incidents may require notification to the CQC, safeguarding referrals to the local authority safeguarding team, communication with families, and internal investigations.
Categories of medicines and why they matter
Medicines used in residential care settings fall into different categories, each carrying different levels of control and risk. General prescription medicines are standard medicines prescribed by a GP or specialist. Over-the-counter medicines can be purchased without a prescription but must still be recorded if administered by staff. High-risk medicines such as insulin or anticoagulants can cause significant harm if used incorrectly. Controlled drugs — including strong pain relief medications such as opioids — are regulated under strict legal controls due to their potential for misuse or dependence. Controlled drugs require secure storage, separate registers, strict stock monitoring and witnessed administration and disposal. Errors involving controlled drugs are treated particularly seriously and may trigger regulatory investigations.
Professional accountability
Where a registered nurse is involved in medication administration — which is the case in all nursing homes — professional accountability applies through the Nursing and Midwifery Council (NMC). Serious medication errors can be reported against a nurse’s NMC PIN registration. Depending on the circumstances, this could result in professional investigation, conditions placed on practice, or suspension or removal from the professional register. This is a meaningful additional layer of risk that nursing homes must manage, and it reinforces the importance of robust, evidenced medication administration records.
Why eMAR systems are the practical solution
Because of these risks, care homes implement structured medication management systems to reduce the likelihood of errors and demonstrate regulatory compliance. Increasingly, care homes use electronic Medication Administration Record (eMAR) systems. Where these systems are integrated directly with dispensing pharmacies, they automatically update prescriptions, improve stock tracking and inventory management, reduce transcription errors from paper charts, and provide comprehensive audit trails for medication administration.
Errors in medication management often originate from incorrect transcription, poor inventory tracking, or incomplete records — digital eMAR systems address these risks by improving accuracy, accountability and visibility across the entire medication process. In short, eMAR systems exist because the stakes of getting medication management wrong in a residential care home are very high — for residents, for staff, and for the organisation.
In a care home, medication is administered to a group of residents who all live in the same building. Care staff carry out medication rounds at set times — typically morning, lunchtime, evening and night — working through each resident in turn. All residents are present in one location, and the medication administration process is centralised and structured around these rounds.
Because the setting is a single building with a large number of residents, each of whom may be taking multiple medicines, the volume and complexity of medication management is high. This is why dedicated standalone eMAR systems — focused entirely on medication administration, pharmacy integration and audit — are the standard approach for residential care.
The demand for eMAR in residential care is concentrated in two types of care home, and understanding the difference matters because the clinical and operational requirements differ.
| Nursing Homes | Residential Care Homes |
| Higher clinical complexity. A registered nurse must be employed to oversee residents’ care. Residents typically manage multiple long-term conditions with complex medication regimes. The nurse oversees medication rounds and is accountable for clinical decisions.
Because a nurse is employed, there is also professional accountability through the NMC. Medication errors carry personal professional consequences alongside the organisational and regulatory ones. eMAR priority: High complexity. Multiple medications per resident, clinical oversight, barcode verification, pharmacy integration. Omnicell, ATLAS and MED e-care are typically the best fit. |
Lower clinical complexity. A registered nurse is not required to be employed. Residents have lower assessed care needs and are overseen by a trained care team. Clinical support is provided externally by district nurses and GPs rather than an in-house nurse.
Despite lower clinical staffing requirements, residents are typically older and managing multiple long-term conditions simultaneously — a pattern known as polypharmacy. Medication volumes are still significant and eMAR is just as important here. eMAR priority: Significant. Residents are older and often have high medication complexity. A reliable, user-friendly eMAR with pharmacy integration is the priority. |
| The key point about medication complexity in older people’s care homes
Both nursing homes and residential care homes serving older people typically have the highest medication complexity of any care setting. Older residents commonly manage multiple long-term conditions simultaneously — polypharmacy. The volume and variety of medications per resident is significant, and even a residential home without a nurse has residents with complex medication needs. This is the primary driver of eMAR adoption in residential care. A smaller care home supporting younger adults with other health challenges may have lower medication complexity on average — but all residential settings benefit from the compliance, safety and efficiency that eMAR provides. |
More About Controlled Drugs — How eMAR Helps
Controlled drugs (CDs) in care homes are managed under strict regulations focusing on secure storage in locked, wall-fixed metal cabinets, meticulous record-keeping in a dedicated CD register, and specialised handling protocols. Transactions often require two staff members to witness and check balances, adhering to CQC regulations and the Misuse of Drugs Act 1971. eMAR systems are specifically designed to support this regulatory burden.
Key Management Requirements
eMAR systems are designed to support the management of controlled drugs in care homes — providing the digital audit trail, witnessed administration recording, stock monitoring and alert systems that manual processes struggle to deliver reliably.
Key CQC Regulations and Requirements — How eMAR Helps
The following CQC regulations directly relate to medication management in residential care homes. eMAR systems are specifically designed to support compliance with each of these requirements.
Need help? CareTechGuide provides independent, unbiased support to help care providers select and implement the right technology. Support ranges from advice through to full procurement, implementation and training — tailored to your budget and strategy,and delivered via vetted independent experts. Contact: [email protected].
We promise that you will only be given independent advice and provide context for all options outlined..
